Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urethral Stricture | 5 | 2021 | 7 | 2.960 |
Why?
|
| Urethra | 6 | 2024 | 33 | 2.130 |
Why?
|
| Urologic Surgical Procedures, Male | 4 | 2021 | 15 | 1.710 |
Why?
|
| Fournier Gangrene | 2 | 2017 | 4 | 1.110 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2024 | 23 | 0.940 |
Why?
|
| Penile Diseases | 3 | 2020 | 9 | 0.940 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2024 | 37 | 0.920 |
Why?
|
| Skin Transplantation | 2 | 2021 | 14 | 0.880 |
Why?
|
| Reconstructive Surgical Procedures | 2 | 2021 | 72 | 0.830 |
Why?
|
| Penile Prosthesis | 2 | 2020 | 2 | 0.810 |
Why?
|
| Penile Implantation | 2 | 2020 | 2 | 0.810 |
Why?
|
| Mouth Mucosa | 1 | 2021 | 13 | 0.740 |
Why?
|
| Postoperative Complications | 3 | 2024 | 604 | 0.720 |
Why?
|
| Contracture | 1 | 2020 | 4 | 0.700 |
Why?
|
| Ejaculation | 1 | 2019 | 1 | 0.660 |
Why?
|
| Penile Erection | 1 | 2019 | 3 | 0.660 |
Why?
|
| Urination | 1 | 2019 | 13 | 0.650 |
Why?
|
| Male | 16 | 2024 | 12870 | 0.620 |
Why?
|
| Adult | 9 | 2024 | 7383 | 0.580 |
Why?
|
| Genitalia, Male | 1 | 2017 | 6 | 0.560 |
Why?
|
| Genital Diseases, Male | 1 | 2017 | 9 | 0.560 |
Why?
|
| Vasectomy | 1 | 2017 | 10 | 0.560 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2016 | 6 | 0.550 |
Why?
|
| Pain, Postoperative | 1 | 2017 | 59 | 0.540 |
Why?
|
| Length of Stay | 1 | 2016 | 215 | 0.500 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2015 | 3 | 0.490 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 15 | 0.490 |
Why?
|
| Penis | 4 | 2020 | 16 | 0.480 |
Why?
|
| Humans | 17 | 2024 | 26829 | 0.430 |
Why?
|
| Middle Aged | 6 | 2024 | 6818 | 0.410 |
Why?
|
| Prostatic Neoplasms | 1 | 2015 | 270 | 0.390 |
Why?
|
| Aged | 5 | 2024 | 5167 | 0.380 |
Why?
|
| Treatment Outcome | 5 | 2024 | 2264 | 0.380 |
Why?
|
| Retrospective Studies | 4 | 2024 | 2433 | 0.360 |
Why?
|
| Anastomosis, Surgical | 2 | 2021 | 37 | 0.340 |
Why?
|
| Recurrence | 2 | 2021 | 316 | 0.290 |
Why?
|
| Robotic Surgical Procedures | 2 | 2017 | 43 | 0.250 |
Why?
|
| Wounds and Injuries | 2 | 2017 | 166 | 0.240 |
Why?
|
| Perioperative Care | 1 | 2024 | 35 | 0.230 |
Why?
|
| Urinary Tract Infections | 1 | 2024 | 39 | 0.230 |
Why?
|
| Cystoscopy | 2 | 2020 | 16 | 0.210 |
Why?
|
| Incidence | 1 | 2024 | 545 | 0.210 |
Why?
|
| Young Adult | 2 | 2021 | 2581 | 0.200 |
Why?
|
| Balanitis Xerotica Obliterans | 1 | 2021 | 1 | 0.190 |
Why?
|
| Hypospadias | 1 | 2021 | 3 | 0.190 |
Why?
|
| Operative Time | 2 | 2021 | 40 | 0.180 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 980 | 0.180 |
Why?
|
| Child | 4 | 2020 | 2147 | 0.180 |
Why?
|
| Time Factors | 1 | 2024 | 1562 | 0.180 |
Why?
|
| Cystoscopes | 1 | 2020 | 1 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 496 | 0.170 |
Why?
|
| Constriction, Pathologic | 1 | 2020 | 34 | 0.170 |
Why?
|
| Endoscopy | 1 | 2020 | 53 | 0.170 |
Why?
|
| Urinary Bladder | 1 | 2020 | 118 | 0.160 |
Why?
|
| Silicones | 1 | 2018 | 8 | 0.160 |
Why?
|
| Urogenital Surgical Procedures | 1 | 2018 | 9 | 0.160 |
Why?
|
| Laparoscopy | 2 | 2017 | 143 | 0.160 |
Why?
|
| Cecostomy | 1 | 2017 | 4 | 0.140 |
Why?
|
| Prognosis | 2 | 2017 | 759 | 0.140 |
Why?
|
| Fecal Incontinence | 1 | 2017 | 16 | 0.140 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2017 | 4 | 0.140 |
Why?
|
| Subcutaneous Tissue | 1 | 2017 | 3 | 0.140 |
Why?
|
| Spermatic Cord | 1 | 2017 | 3 | 0.140 |
Why?
|
| Amputation, Traumatic | 1 | 2017 | 5 | 0.140 |
Why?
|
| Accidental Falls | 1 | 2017 | 31 | 0.140 |
Why?
|
| Burns | 1 | 2017 | 16 | 0.140 |
Why?
|
| Surgical Flaps | 1 | 2017 | 22 | 0.140 |
Why?
|
| Patient Safety | 1 | 2017 | 36 | 0.140 |
Why?
|
| Patient Participation | 1 | 2017 | 52 | 0.140 |
Why?
|
| Testis | 1 | 2017 | 39 | 0.140 |
Why?
|
| Fear | 1 | 2017 | 58 | 0.140 |
Why?
|
| Pain Measurement | 1 | 2017 | 159 | 0.130 |
Why?
|
| Adolescent | 2 | 2021 | 2957 | 0.130 |
Why?
|
| Emotions | 1 | 2017 | 131 | 0.130 |
Why?
|
| Skin | 1 | 2017 | 140 | 0.130 |
Why?
|
| Caregivers | 1 | 2017 | 110 | 0.130 |
Why?
|
| Risk Factors | 1 | 2021 | 2011 | 0.130 |
Why?
|
| Vincristine | 1 | 2015 | 9 | 0.120 |
Why?
|
| Etoposide | 1 | 2015 | 19 | 0.120 |
Why?
|
| Bleomycin | 1 | 2015 | 11 | 0.120 |
Why?
|
| Prostatectomy | 1 | 2015 | 83 | 0.120 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 225 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 150 | 0.120 |
Why?
|
| Cisplatin | 1 | 2015 | 172 | 0.110 |
Why?
|
| Teratogens | 1 | 2012 | 4 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 367 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 1927 | 0.090 |
Why?
|
| Registries | 1 | 2012 | 383 | 0.090 |
Why?
|
| Fetus | 2 | 2012 | 77 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 657 | 0.070 |
Why?
|
| Child, Preschool | 2 | 2020 | 1091 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1217 | 0.060 |
Why?
|
| Neoplasms | 1 | 2012 | 755 | 0.060 |
Why?
|
| Sex Differentiation | 1 | 2000 | 1 | 0.050 |
Why?
|
| Phthalic Acids | 1 | 2000 | 6 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2021 | 52 | 0.040 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 2012 | 10 | 0.040 |
Why?
|
| Neurogenic Bowel | 1 | 2017 | 4 | 0.040 |
Why?
|
| Appendix | 1 | 2017 | 9 | 0.040 |
Why?
|
| Rupture | 1 | 2017 | 11 | 0.040 |
Why?
|
| Constipation | 1 | 2017 | 21 | 0.040 |
Why?
|
| Catheterization | 1 | 2017 | 50 | 0.040 |
Why?
|
| Urologic Diseases | 1 | 2017 | 6 | 0.040 |
Why?
|
| Humidity | 1 | 2017 | 7 | 0.040 |
Why?
|
| Urologic Surgical Procedures | 1 | 2017 | 22 | 0.030 |
Why?
|
| Clinical Decision-Making | 1 | 2017 | 61 | 0.030 |
Why?
|
| Female | 4 | 2017 | 14463 | 0.030 |
Why?
|
| Intraoperative Complications | 1 | 2017 | 47 | 0.030 |
Why?
|
| Ultrasonography | 1 | 2017 | 228 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 250 | 0.030 |
Why?
|
| Age Factors | 1 | 2017 | 716 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 700 | 0.030 |
Why?
|
| Pregnancy | 2 | 2012 | 1131 | 0.030 |
Why?
|
| Maternal Death | 1 | 2012 | 2 | 0.030 |
Why?
|
| Pregnancy Trimesters | 1 | 2012 | 5 | 0.030 |
Why?
|
| Abortion, Spontaneous | 1 | 2012 | 15 | 0.030 |
Why?
|
| Stillbirth | 1 | 2012 | 14 | 0.030 |
Why?
|
| Fetal Death | 1 | 2012 | 21 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2012 | 276 | 0.020 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2000 | 6 | 0.010 |
Why?
|
| Androgen Antagonists | 1 | 2000 | 17 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 2000 | 30 | 0.010 |
Why?
|
| Species Specificity | 1 | 2000 | 186 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 545 | 0.010 |
Why?
|
| Rats | 1 | 2000 | 1546 | 0.010 |
Why?
|
| Animals | 1 | 2000 | 9963 | 0.000 |
Why?
|